We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Vertigo and Dizziness After Coronavirus Disease-2019 Vaccination: A Nationwide Analysis.
- Authors
Sang Hoon Kim; Dong Keon Yon; Yong Sung Choi; Jinseok Lee; Ki-Ho Park; Young Ju Lee; Dong Choon Park; Sung Soo Kim; Hwa Sung Rim; Seung Geun Yeo
- Abstract
BACKGROUND: Side effects occurring after COVID-19 vaccination can include vertigo and dizziness. Despite its high incidence, few studies to date have assessed dizziness/vertigo after vaccination. The present study investigated the incidence of dizziness/vertigo after COVID-19 vaccination in South Korea. METHODS: Adverse reactions to COVID-19 vaccination reported to the Korea Disease Control and Prevention Agency from February 26, 2021, to July 31, 2022 (week 74) were analyzed. The incidence rates of dizziness/vertigo in subjects vaccinated with 5 COVID-19 vaccines, AZD1222 (AstraZeneca), BNT162b2 (Pfizer-BioNTech), JNJ-78436735 (Janssen), mRNA-1273 (Moderna), and NVX-CoV2373 (Novavax), were determined. RESULTS: A total of 126 725 952 doses of COVID-19 vaccine were administered, with 473 755 suspected adverse reactions (374 per 100 000 vaccinations) reported. Vertigo/dizziness was reported after the administration of 68 759 doses, or 54.3 per 100 000 vaccinations, making it the third most common adverse reaction after headache and muscle pain. CONCLUSION: Dizziness/vertigo was generally a mild adverse reaction after COVID-19 vaccination, but it was the third most common adverse reaction in Korea. Studies are necessary to clarify the causal relationship between vaccination and dizziness/vertigo and to prepare subjects for this possible adverse reaction.
- Subjects
SOUTH Korea; ASTRAZENECA PLC; CORONAVIRUSES; DIZZINESS; VACCINATION; VERTIGO; COVID-19; COVID-19 vaccines
- Publication
Journal of International Advanced Otology, 2023, Vol 19, Issue 3, p228
- ISSN
1308-7649
- Publication type
Article
- DOI
10.5152/iao.2023.22937